Canaccord Genuity Starts Aerie Pharma (AERI) at Buy
Tweet
Share
E-mailGet Alerts AERI Hot Sheet
Price: $15.25 --0%
Rating Summary:
12 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
12 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Aerie Pharma (NASDAQ: AERI) with a Buy rating and a price target of $40.00.
For an analyst ratings summary and ratings history on Aerie Pharma click here. For more ratings news on Aerie Pharma click here.
Shares of Aerie Pharma closed at $23.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Assumes Inova Technology, Inc. (INVA) at Outperform
- Oura launches IPO of 50 million shares on Nasdaq
- StoneX Starts AvidBank Holdings Inc. (AVBH) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
